Assessing the Impact of Insulin Glargine and Detemir Treatment to Serum Total IGF1 Levels in the Insulin-Naive Type 2 Diabetic Patients

CANDER S., ÖZ GÜL Ö., Dizdar O. S., Koca N., Aydin T., SARANDÖL E., ...Daha Fazla

METABOLIC SYNDROME AND RELATED DISORDERS, cilt.15, sa.5, ss.220-225, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1089/met.2017.0005
  • Dergi Adı: METABOLIC SYNDROME AND RELATED DISORDERS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.220-225
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Aim: The mitogenic potential of analog insulins due to their different insulin-like growth factor-1 (IGF1) receptor affinity is a situation that causes concern related to cancer risk. We aimed to examine the changes in the serum IGF1 levels formed by insulin glargine and detemir in the insulin-naive type 2 diabetic patients.